[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter, J
[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis]. [electronic resource] - Der Orthopade Jul 2001 - 462-72 p. digital
Publication Type: Comparative Study; Journal Article; Review
0085-4530
10.1007/s001320170079 doi
Administration, Oral
Age Factors
Aged
Bone Density
Breast Neoplasms--chemically induced
Clinical Trials as Topic
Estradiol--administration & dosage
Estrogen Antagonists--administration & dosage
Estrogen Replacement Therapy--adverse effects
Estrogens, Conjugated (USP)--administration & dosage
Female
Fractures, Bone--prevention & control
Humans
Middle Aged
Osteoporosis, Postmenopausal--drug therapy
Progestins--administration & dosage
Raloxifene Hydrochloride--administration & dosage
Risk Factors
Selective Estrogen Receptor Modulators--therapeutic use
Time Factors
Uterine Neoplasms--chemically induced
[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis]. [electronic resource] - Der Orthopade Jul 2001 - 462-72 p. digital
Publication Type: Comparative Study; Journal Article; Review
0085-4530
10.1007/s001320170079 doi
Administration, Oral
Age Factors
Aged
Bone Density
Breast Neoplasms--chemically induced
Clinical Trials as Topic
Estradiol--administration & dosage
Estrogen Antagonists--administration & dosage
Estrogen Replacement Therapy--adverse effects
Estrogens, Conjugated (USP)--administration & dosage
Female
Fractures, Bone--prevention & control
Humans
Middle Aged
Osteoporosis, Postmenopausal--drug therapy
Progestins--administration & dosage
Raloxifene Hydrochloride--administration & dosage
Risk Factors
Selective Estrogen Receptor Modulators--therapeutic use
Time Factors
Uterine Neoplasms--chemically induced